AI Article Synopsis
- Metabolic and bariatric surgery (MBS) effectively promotes weight loss and improves obesity-related medical issues.
- Research indicates that MBS may lower the risk of certain hormonal cancers, like breast and endometrial cancer.
- The link between bariatric surgery and non-hormonal cancers (esophageal, gastric, liver, gallbladder, colorectal, pancreatic, and kidney) is still debated, prompting this study to explore the connection between obesity, cancer risk, and the impact of MBS on cancer reduction.
Article Abstract
Metabolic and bariatric surgery (MBS) is the most effective intervention for weight loss leading to significant resolution of obesity-related medical conditions. Recent literature has demonstrated risk reduction of certain cancer types after MBS. Studies have shown an overall reduction in the risk of hormonal cancer, such as breast and endometrial cancer. However, the association between bariatric surgery and the incidence of various types of non-hormonal cancer such as esophageal, gastric, liver, gallbladder, colorectal, pancreatic and kidney cancer remains contested. The aim of this study was to highlight obesity and its relationship to cancer development as well as bariatric surgery and its role in cancer reduction with focus on non-hormonal cancers.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.23736/S2724-5691.23.10104-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!